Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis
出版年份 2019 全文链接
标题
Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis
作者
关键词
-
出版物
CIRCULATION RESEARCH
Volume 124, Issue 3, Pages 405-415
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-02-01
DOI
10.1161/circresaha.118.313864
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- Spatiotemporal Multi-omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving Disease
- (2018) Florian Schlotter et al. CIRCULATION
- Relationship between “LDL-C”, estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide
- (2018) Nicholas J. Viney et al. Journal of Clinical Lipidology
- DEDICATED PROGRAM TO ENHANCE MEASUREMENT OF LIPOPROTEIN(A) AMONG PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
- (2018) Gary Ma et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
- (2018) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genome-wide analysis yields new loci associating with aortic valve stenosis
- (2018) Anna Helgadottir et al. Nature Communications
- A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis
- (2018) Sébastien Thériault et al. Nature Communications
- Association of LPA Variants With Aortic Stenosis
- (2018) Hao Yu Chen et al. JAMA Cardiology
- Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
- (2018) Stephen Burgess et al. JAMA Cardiology
- The effect of oxidized phospholipids on phenotypic polarization and function of macrophages
- (2017) Vlad Serbulea et al. FREE RADICAL BIOLOGY AND MEDICINE
- Niacin and heart disease prevention: Engraving its tombstone is a mistake
- (2017) Harold Robert Superko et al. Journal of Clinical Lipidology
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack
- (2017) Young Sup Byun et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
- (2017) Rick A. Nishimura et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The renaissance of lipoprotein(a): Brave new world for preventive cardiology?
- (2017) Katrina L. Ellis et al. PROGRESS IN LIPID RESEARCH
- Normal values for Doppler echocardiographic assessment of prosthetic valve function after transcatheter aortic valve replacement: a systematic review and meta-analysis
- (2017) Max-Paul Winter et al. European Heart Journal-Cardiovascular Imaging
- Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United StatesHighlights
- (2016) Steve Varvel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansClinical Perspective
- (2016) Fleur M. van der Valk et al. CIRCULATION
- Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis
- (2016) Calvin Yeang et al. CURRENT OPINION IN CARDIOLOGY
- PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis
- (2016) Anne Langsted et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease
- (2016) M. J. Nsaibia et al. JOURNAL OF INTERNAL MEDICINE
- Structure, function, and genetics of lipoprotein (a)
- (2016) Konrad Schmidt et al. JOURNAL OF LIPID RESEARCH
- PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor’s role
- (2016) Frederick J. Raal et al. JOURNAL OF LIPID RESEARCH
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques
- (2016) Joshua D. Hutcheson et al. NATURE MATERIALS
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
- (2016) Martin B. Leon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice
- (2016) Rosie Z Yu et al. Molecular Therapy-Nucleic Acids
- Mipomersen, an Antisense Oligonucleotide to Apolipoprotein B-100, Reduces Lipoprotein(a) in Various Populations With HypercholesterolemiaSignificance
- (2015) Raul D. Santos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic ValveCLINICAL PERSPECTIVE
- (2015) Rihab Bouchareb et al. CIRCULATION
- ‘LDL-C’ = LDL-C + Lp(a)-C
- (2015) Calvin Yeang et al. CURRENT OPINION IN LIPIDOLOGY
- Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)
- (2015) Corey A. Scipione et al. JOURNAL OF LIPID RESEARCH
- Valvular 18F-Fluoride and 18F-Fluorodeoxyglucose Uptake Predict Disease Progression and Clinical Outcome in Patients With Aortic Stenosis
- (2015) William S.A. Jenkins et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
- (2015) Romain Capoulade et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
- (2015) Sotirios Tsimikas et al. LANCET
- Calcific Aortic Valve Disease
- (2014) Katherine E. Yutzey et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis: A Prospective Mendelian Randomization Study and Replication in a Case-Control Cohort
- (2014) B. J. Arsenault et al. Circulation-Cardiovascular Genetics
- 18F-Sodium Fluoride Uptake Is a Marker of Active Calcification and Disease Progression in Patients With Aortic Stenosis
- (2014) Marc R. Dweck et al. Circulation-Cardiovascular Imaging
- Association of Low-Density Lipoprotein Cholesterol–Related Genetic Variants With Aortic Valve Calcium and Incident Aortic Stenosis
- (2014) J. Gustav Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
- (2014) Rick A. Nishimura et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evaluation of Links Between High-Density Lipoprotein Genetics, Functionality, and Aortic Valve Stenosis Risk in Humans
- (2013) Benoit J. Arsenault et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)
- (2013) Gregor Leibundgut et al. JOURNAL OF LIPID RESEARCH
- Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Associations with Valvular Calcification and Aortic Stenosis
- (2013) George Thanassoulis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis
- (2012) Raj R. Makkar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events
- (2011) Adam Taleb et al. Biomarkers in Medicine
- Calcific Aortic Valve Disease: Not Simply a Degenerative Process
- (2011) Nalini M. Rajamannan et al. CIRCULATION
- The Roles of Lipid Oxidation Products and Receptor Activator of Nuclear Factor-κB Signaling in Atherosclerotic Calcification
- (2011) Linda Demer et al. CIRCULATION RESEARCH
- Network for Activation of Human Endothelial Cells by Oxidized Phospholipids
- (2011) Casey E. Romanoski et al. CIRCULATION RESEARCH
- Antisense Oligonucleotide Lowers Plasma Levels of Apolipoprotein (a) and Lipoprotein (a) in Transgenic Mice
- (2011) Esther Merki et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis
- (2010) Kwan Leung Chan et al. CIRCULATION
- Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors
- (2009) Sotirios Tsimikas et al. CIRCULATION
- Aortic stenosis
- (2009) Blase A Carabello et al. LANCET
- Prognosis and Risk Factors in Patients With Asymptomatic Aortic Stenosis and Their Modulation by Atorvastatin (20 mg)
- (2008) Wolfgang Dichtl et al. AMERICAN JOURNAL OF CARDIOLOGY
- Antisense Oligonucleotide Directed to Human Apolipoprotein B-100 Reduces Lipoprotein(a) Levels and Oxidized Phospholipids on Human Apolipoprotein B-100 Particles in Lipoprotein(a) Transgenic Mice
- (2008) Esther Merki et al. CIRCULATION
- The role of oxidized phospholipids in atherosclerosis: Fig. 1.
- (2008) Judith A. Berliner et al. JOURNAL OF LIPID RESEARCH
- A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
- (2008) Claes Bergmark et al. JOURNAL OF LIPID RESEARCH
- Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
- (2008) Anne B. Rossebø et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started